The Effects of Combined Social Cognition and Interaction Training and Paliperidone on Early-Onset Schizophrenia

Frontiers in Psychiatry
Yichen LiXiaofan Zhang

Abstract

The limitations associated with antipsychotics in early-onset schizophrenia patients have stimulated more interest in psychological interventions in this population. Nevertheless, the isolated psychosocial interventions are unrealistic in a treatment success covering the complex array of symptoms, and the psychosocial interventions could be an adjunct treatment to the pharmacological treatment. It is necessary to find the benefits of psychological interventions with limited and targeted use of antipsychotics. Social cognition and interaction training (SCIT) was a program for social cognitive rehabilitation in adult schizophrenia. However, it is unclear how generalizable this is to early-onset patients. The current study tested this hypothesis that combined SCIT and paliperidone was superior to paliperidone alone in treating early-onset schizophrenia patients on cognitive, functional, and symptom outcomes. Two hundred eight inpatients with schizophrenia aged 13 to 17 years old participated in a 24-week work intervention program. Patients completed a battery of measures administered at a pre-SCIT intervention baseline, 4, 8, 12, and 24 weeks post-SCIT, respectively. SCIT had significant added benefits above paliperidone for the s...Continue Reading

References

Dec 1, 1992·Journal of Autism and Developmental Disorders·J S Werry
Apr 1, 1997·The American Journal of Psychiatry·H Y MeltzerP A Thompson
Nov 22, 2000·Schizophrenia Bulletin·B LayM H Schmidt
Aug 3, 2002·The American Journal of Psychiatry·James M GoldAnthony F Lehman
Feb 3, 2004·The American Journal of Psychiatry·Alan S BellackYe Yang
Feb 26, 2004·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Joan Rosenbaum AsarnowEmily P McGrath
Nov 9, 2004·Schizophrenia Research·Michael F GreenRobert K Heaton
Jun 29, 2005·Schizophrenia Research·Stefan LeuchtRolf R Engel
Sep 6, 2005·Schizophrenia Research·David PennBrian Sheitman
Jan 31, 2006·Schizophrenia Research·Nadine RevheimDaniel C Javitt
Mar 3, 2006·Neuropsychological Rehabilitation·Nadja KayserMarie-Christine Hardy-Baylé
Aug 4, 2006·Schizophrenia Bulletin·Alex KopelowiczRoberto Zarate
Apr 7, 2007·Psychiatric Services : a Journal of the American Psychiatric Association·David L PennAbram Sterne
May 23, 2007·Journal of Abnormal Psychology·Erin A Heerey, James M Gold
Oct 19, 2007·Acta Psychiatrica Scandinavica·T Burns, D Patrick
May 10, 2008·BMC Psychiatry·Graham K MurrayLuise Poustka
Aug 23, 2008·Journal of Clinical and Experimental Neuropsychology·Philip D HarveyChristopher R Bowie
Oct 15, 2008·Current Opinion in Psychiatry·Georg Juckel, Pier Luigi Morosini
Jan 13, 2009·Psychiatry Research·Anja VaskinnOle A Andreassen
Mar 11, 2010·Journal of the American Academy of Child and Adolescent Psychiatry·Stephen R HooperJeffrey A Lieberman
Jul 14, 2010·Neuroscience and Biobehavioral Reviews·Anne-Kathrin J FettLydia Krabbendam
Oct 15, 2010·Journal of Psychopharmacology·Hiram Joseph WildgustMike Beary
Apr 25, 2012·Journal of the American Academy of Child and Adolescent Psychiatry·Jean A FrazierStephen R Hooper
Jul 27, 2014·Journal of the American Academy of Child and Adolescent Psychiatry·Olga PuigJosefina Castro-Fornieles
May 5, 2016·Behavioural and Cognitive Psychotherapy·Greta VoutilainenJorma Oksanen
Jul 5, 2017·Schizophrenia Research·Andrew W BismarkGregory A Light

❮ Previous
Next ❯

Methods Mentioned

BETA
SANS

Software Mentioned

SCIT
MATRICS

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here